Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Maddalena Tumedei

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Analytical Cellular Pathology (Amsterdam)|May 19, 2012
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CINSara Bravaccini, Andrea Amadori, Emanuela Scarpi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Expert Opinion on Therapeutic Targets|August 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancerMichela Cortesi, Michele Zanoni, Roberta Maltoni, et al.
The International Journal of Biological Markers|August 14, 2018
Carcinosarcoma of the prostate: case report with molecular and histological characterizationSamanta Salvi, Valentina Casadio, Filippo Martignano, et al.
International Journal of Experimental Pathology|December 2, 2017
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapySara Ravaioli, Maria Maddalena Tumedei, Flavia Foca, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Data Science for Health Image Alignment: A User-Friendly Open-Source ImageJ/Fiji Plugin for Aligning Multimodality/Immunohistochemistry/Immunofluorescence 2D Microscopy ImagesFilippo Piccinini, Marcella Tazzari, Maria Maddalena Tumedei, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Cancer Immunology, Immunotherapy : CII|July 30, 2020
Are we ready to use TMB in breast cancer clinical practice?Sara Ravaioli, Francesco Limarzi, Maria Maddalena Tumedei, et al.
Analytical Cellular Pathology (Amsterdam)|May 19, 2012
Predictive role of telomerase activity in the clinical outcome of patients with benign lesions of the uterine cervix or CINSara Bravaccini, Andrea Amadori, Emanuela Scarpi, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 3, 2017
Are Androgen and Estrogen Receptors in DCIS Patients Prognostic Indicators of Relapse Independently of Treatment?Sara Ravaioli, Maurizio Puccetti, Maria Maddalena Tumedei, et al.
Oncotarget|November 12, 2016
Easily detectable cytomorphological features to evaluate during ROSE for rapid lung cancer diagnosis: from cytology to histologySara Ravaioli, Sara Bravaccini, Maria Maddalena Tumedei, et al.
Frontiers in Cell and Developmental Biology|January 23, 2023
Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiotaFrancesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, et al.
Diagnostic Pathology|September 12, 2020
Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be goldRoberta Maltoni, Michela Palleschi, Sara Ravaioli, et al.
Expert Opinion on Therapeutic Targets|August 13, 2022
TROP2 (trophoblast cell-surface antigen 2): a drug target for breast cancerMichela Cortesi, Michele Zanoni, Roberta Maltoni, et al.
The International Journal of Biological Markers|August 14, 2018
Carcinosarcoma of the prostate: case report with molecular and histological characterizationSamanta Salvi, Valentina Casadio, Filippo Martignano, et al.
International Journal of Experimental Pathology|December 2, 2017
Androgen and oestrogen receptors as potential prognostic markers for patients with ductal carcinoma in situ treated with surgery and radiotherapySara Ravaioli, Maria Maddalena Tumedei, Flavia Foca, et al.
Sensors (Basel, Switzerland)|January 23, 2024
Data Science for Health Image Alignment: A User-Friendly Open-Source ImageJ/Fiji Plugin for Aligning Multimodality/Immunohistochemistry/Immunofluorescence 2D Microscopy ImagesFilippo Piccinini, Marcella Tazzari, Maria Maddalena Tumedei, et al.
Pageof 5